If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

Share Price is delayed by 15 minutes
Get Live Data
2,290.00    -22.00 (-0.95%)
Bid:
2,288.00
Ask:
2,292.00
Spread: 4.00 (0.175%)
Market Cap: £1.52b
GNS Live PriceLast checked at - London Stock Exchange

Intraday Genus Share Chart

Director/PDMR Shareholding

26 Sep 2012 16:01

RNS Number : 2489N
Genus PLC
26 September 2012
 



26 September 2012

 

Genus plc

 

('Genus' or 'the Company')

 

Director/PDMR Shareholdings

 

 

Genus announces that 21,008 ordinary shares of 10 pence each in the Company ("Share(s)") were today sold on behalf of John Worby, Group Finance Director, at a price of 1,474.68 pence per Share. This sale was made further to the vesting of 42,017 conditional nil-cost Share options on 17 September 2012 under the Company's Performance Share Plan ("the PSP") and represents the exercise by John Worby of one half of his vesting entitlement. The remaining 21,009 Share options that vested under the PSP in September 2012 have been retained by John Worby and have not been exercised.

 

John Worby's direct shareholding in the Company stands at 10,000 Shares, representing 0.02% of the issued share capital of the Company that is currently 60,354,170 Shares. In addition, he is the owner of 64,271 nil-cost Share options that have vested under the PSP and he remains the beneficial owner of 68,360 conditional nil-cost Share options under the PSP.

 

Genus also announces that:

 

(i) 3,619 Shares were today sold on behalf of Bill Christianson, Chief Operating Officer, Genus PIC, at a price of 1,474.68 pence per Share. This sale was made further to the vesting of 18,970 market value Share options on 17 September 2012 under the Company's Executive Share Option Plan ("the ESOP"). Bill Christianson's direct shareholding in the Company stands at 6,932 Shares representing 0.01% of the issued share capital of the Company. In addition, he remains the beneficial owner of 56,953 conditional nil-cost Share options under the PSP.

 

(ii) 2,354 Shares were today sold on behalf of Ricardo Campos, Chief Operating Officer, Genus ABS, at a price of 1,474.68 pence per Share. This sale was made further to the vesting of 8,466 market value Share options on 17 September 2012 under the ESOP. Ricardo Campos has no direct shareholding in the Company and is the owner of 4,233 market value Share options that have vested under the ESOS and the beneficial owner of 38,696 conditional market value Share options under the ESOS.

 

(iii) 5,184 Shares were today sold on behalf of Jerry Thompson, Chief Operating Officer, Genus Asia, at a price of 1,474.68 pence per Share. This sale was made further to the vesting of 18,640 market value Share options on 17 September 2012 under the ESOP. Jerry Thompson has no direct shareholding in the Company and is the owner of 9,320 market value Share options that have vested under the ESOS and he is the beneficial owner of 21,452 conditional nil-cost Share options under the PSP and 17,545 conditional market value Share options under the ESOS

 

(iv) 10,499 Shares were today sold on behalf of Denny Funk, Chief Scientific Officer, at a price of 1,474.68 pence per Share. This sale was made further to the vesting of 18,878 market value Share options on 17 September 2012 under the ESOP. Denny Funk has no direct shareholding in the Company and is the beneficial owner of 25,568 market value Share options under the ESOS.

 

(v) 22,154 Shares were today sold on behalf of Ian Farrelly, Group Company Secretary & General Counsel, at a price of 1,474.68 pence per Share. This sale was made further to the vesting of 22,154 nil-cost Share options on 17 September 2012 under the PSP. Ian Farrelly has no direct shareholding in the Company and is the beneficial owner of 39,308 nil-cost Share options under the PSP.

 

(vi) 19,404 Shares were today sold on behalf of David Crosby, Group Financial Controller, at a price of 1,474.68 pence per Share. This sale was made further to the vesting of 19,404 nil-cost Share options on 17 September 2012 under the PSP. David Crosby has no direct shareholding in the Company and is the beneficial owner of 34,439 nil-cost Share options under the PSP.

 

 

For further information please contact:

 

Cara Crichton

Assistant Company Secretary

Genus plc

 

Tel: 01256 345996

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUNVSRUKAKUAR
Date   Source Headline
28th Feb 20251:30 pmRNSDirector/PDMR Shareholding
27th Feb 20257:00 amRNSInterim Results
26th Feb 20257:00 amRNSNon-Executive Director Retirement
3rd Feb 20253:17 pmRNSBlock Listing Six Monthly Return
3rd Feb 20259:40 amRNSTotal Voting Rights
15th Jan 20257:00 amRNSHalf Year Trading Update – Ahead of expectations
12th Dec 20245:07 pmRNSNotification of Major Holdings
20th Nov 20243:32 pmRNSResults of AGM
20th Nov 20247:00 amRNSAGM Trading Update
1st Nov 202410:42 amRNSTotal Voting Rights
22nd Oct 20247:00 amRNSChief Financial Officer Retirement
14th Oct 20247:00 amRNSAnnual Report and Annual General Meeting
18th Sep 202411:17 amRNSDirector/PDMR Shareholding
16th Sep 20244:29 pmRNSDirector/PDMR Shareholding
12th Sep 20244:51 pmRNSDirector/PDMR Shareholding
12th Sep 20247:00 amRNSDirector/PDMR Shareholding
9th Sep 20247:00 amRNSDirector/PDMR Shareholding
6th Sep 202412:31 pmRNSDirector/PDMR Shareholding
6th Sep 202412:30 pmRNSDirector/PDMR Shareholding
5th Sep 20247:00 amRNSPreliminary Results
1st Aug 20244:26 pmRNSBlock Listing Six Monthly Return
1st Aug 20243:38 pmRNSTotal Voting Rights
17th Jul 20247:00 amRNSTrading Update
3rd Jun 202410:48 amRNSHolding(s) in Company
1st May 20241:59 pmRNSTotal Voting Rights
22nd Feb 20247:00 amRNSInterim Results
15th Feb 20247:00 amRNSTrading Update
1st Feb 20244:24 pmRNSBlock listing Interim Review
1st Feb 20244:21 pmRNSTotal Voting Rights
12th Dec 20237:00 amRNSNon-Executive Director Appointment
22nd Nov 20231:08 pmRNSResult of AGM
22nd Nov 20237:00 amRNSAGM Trading Update
1st Nov 20234:46 pmRNSTotal Voting Rights
1st Nov 20237:00 amRNSCapital Markets Event
13th Oct 20237:00 amRNSAnnual Report and Annual General Meeting
5th Oct 202310:19 amRNSPos. determination-PRRS resistant pigs-Colombia
2nd Oct 202311:12 amRNSTotal Voting Rights
15th Sep 20231:07 pmRNSDirector/PDMR Shareholding
15th Sep 202310:04 amRNSDirector/PDMR Shareholding
7th Sep 20237:00 amRNSPreliminary Results
25th Aug 20238:35 amRNSNotification of Major Holdings
23rd Aug 20239:25 amRNSDirectorate Change
1st Aug 202311:41 amRNSBlock listing Interim Review
1st Aug 202311:36 amRNSTotal Voting Rights
3rd Jul 202311:02 amRNSTotal Voting Rights
16th Jun 20235:33 pmRNSNational Milk Records plc - Form 8.3
16th Jun 20235:10 pmRNSForm 8.3 (OPD) - National Milk Records plc
8th Jun 20233:51 pmRNSDirector/PDMR Shareholding
7th Jun 20235:11 pmRNSNotification of Major Holdings
7th Jun 20235:08 pmRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.